Portfolio company
Implexis
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Implexis provides a software platform using an optimisation algorithm to accelerate pharmaceutical formulation development for drug manufacturers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Perceptic
This company develops a software platform to integrate data and decision-making workflows across the drug development lifecycle for pharmaceutical and biotechnology organisations.
Persist AI
Persist AI provides a cloud-based robotics and artificial intelligence platform to help pharmaceutical companies automate and accelerate drug formulation development.
Disruptive Pharma
This company develops a drug formulation platform to improve the solubility and bioavailability of pharmaceutical compounds for the healthcare industry.
PolyModels Hub
This company develops a digital platform for biopharma process development to help scientists design, simulate and optimise pharmaceutical manufacturing workflows.
Plex
Plex Research develops an AI-powered search and analysis platform for drug discovery for biotechnology and pharmaceutical companies.
Solve Chemistry
This company provides an automated laboratory platform and predictive software to optimise chemical process development for pharmaceutical, agrochemical and specialty chemical customers.
Duplicat
This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.
InSilicoTrials
This company develops a cloud-based simulation and modelling platform for pharmaceutical and medical device organisations to accelerate research and regulatory processes.
